Molecular Recognition of Leucine-Aspartate Repeat (LD) Motifs by the Focal Adhesion Targeting Homology Domain of Cerebral Cavernous Malformation 3 (CCM3)*

Cerebral cavernous malformation (CCM) is a disease that affects between 0.1 and 0.5% of the human population, with mutations in CCM3 accounting for ∼15% of the autosomal dominant form of the disease. We recently reported that CCM3 contains an N-terminal dimerization domain (CCM3D) and a C-terminal focal adhesion targeting (FAT) homology domain. Intermolecular protein-protein interactions of CCM3 are mediated by a highly conserved surface on the FAT homology domain and are affected by CCM3 truncations in the human disease. Here we report the crystal structures of CCM3 in complex with three different leucine-aspartate repeat (LD) motifs (LD1, LD2, and LD4) from the scaffolding protein paxillin, at 2.8, 2.7, and 2.5 Å resolution. We show that CCM3 binds LD motifs using the highly conserved hydrophobic patch 1 (HP1) and that this binding is similar to the binding of focal adhesion kinase and Pyk2 FAT domains to paxillin LD motifs. We further show by surface plasmon resonance that CCM3 binds paxillin LD motifs with affinities in the micromolar range, similar to FAK family FAT domains. Finally, we show that endogenous CCM3 and paxillin co-localize in mouse cerebral pericytes. These studies provide a molecular-level framework to investigate the protein-protein interactions of CCM3.

[1]  Ying Zhang,et al.  Crystal structure of human programmed cell death 10 complexed with inositol-(1,3,4,5)-tetrakisphosphate: a novel adaptor protein involved in human cerebral cavernous malformation. , 2010, Biochemical and biophysical research communications.

[2]  W. Sessa,et al.  CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. , 2010, The Journal of clinical investigation.

[3]  W. Min,et al.  Crystal Structure of CCM3, a Cerebral Cavernous Malformation Protein Critical for Vascular Integrity* , 2010, The Journal of Biological Chemistry.

[4]  T. Force,et al.  CCM3/PDCD10 stabilizes GCKIII proteins to promote Golgi assembly and cell orientation , 2010, Journal of Cell Science.

[5]  W. Min,et al.  Stabilization of VEGFR2 Signaling by Cerebral Cavernous Malformation 3 Is Critical for Vascular Development , 2010, Science Signaling.

[6]  J. Schlessinger,et al.  Crystal structures of free and ligand-bound focal adhesion targeting domain of Pyk2. , 2009, Biochemical and biophysical research communications.

[7]  U. Felbor,et al.  Functional analyses of human and zebrafish 18–amino acid in‐frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein , 2009, Human mutation.

[8]  Brian Raught,et al.  A PP2A Phosphatase High Density Interaction Network Identifies a Novel Striatin-interacting Phosphatase and Kinase Complex Linked to the Cerebral Cavernous Malformation 3 (CCM3) Protein*S , 2009, Molecular & Cellular Proteomics.

[9]  Iain D. Campbell,et al.  Structural Analysis of the Interactions Between Paxillin LD Motifs and α-Parvin , 2008, Structure.

[10]  C. Turner,et al.  Paxillin comes of age , 2008, Journal of Cell Science.

[11]  A. Gronenborn,et al.  The Structure of α-Parvin CH2-Paxillin LD1 Complex Reveals a Novel Modular Recognition for Focal Adhesion Assembly* , 2008, Journal of Biological Chemistry.

[12]  Jie J. Zheng,et al.  GIT1 Paxillin-binding Domain Is a Four-helix Bundle, and It Binds to Both Paxillin LD2 and LD4 Motifs* , 2008, Journal of Biological Chemistry.

[13]  J. Kyriakis,et al.  SOK1 Translocates from the Golgi to the Nucleus upon Chemical Anoxia and Induces Apoptotic Cell Death* , 2008, Journal of Biological Chemistry.

[14]  Jean-François Guichou,et al.  Structural basis for the interaction between focal adhesion kinase and CD4. , 2008, Journal of molecular biology.

[15]  K. Henrick,et al.  Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.

[16]  S. Arold,et al.  GIT1 utilizes a focal adhesion targeting-homology domain to bind paxillin. , 2007, Cellular signalling.

[17]  U. Felbor,et al.  CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations , 2007, Neurogenetics.

[18]  Xiao Han,et al.  PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway. , 2007, Molecular biology of the cell.

[19]  M. Moran,et al.  Large-scale mapping of human protein–protein interactions by mass spectrometry , 2007, Molecular systems biology.

[20]  E. Tournier-Lasserve,et al.  Genetics of cavernous angiomas , 2007, The Lancet Neurology.

[21]  Chi-Ying F. Huang,et al.  Inhibition of Cell Migration by Autophosphorylated Mammalian Sterile 20-Like Kinase 3 (MST3) Involves Paxillin and Protein-tyrosine Phosphatase-PEST* , 2006, Journal of Biological Chemistry.

[22]  M. Vikkula,et al.  Cerebral cavernous malformation: new molecular and clinical insights , 2006, Journal of Medical Genetics.

[23]  B. O’Roak,et al.  Mutations in Apoptosis-related Gene, PDCD10, Cause Cerebral Cavernous Malformation 3 , 2005, Neurosurgery.

[24]  S. L. Wong,et al.  Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.

[25]  Jie J. Zheng,et al.  Structural features of the focal adhesion kinase–paxillin complex give insight into the dynamics of focal adhesion assembly , 2005, Protein science : a publication of the Protein Society.

[26]  C. Turner,et al.  Paxillin: adapting to change. , 2004, Physiological reviews.

[27]  Robert Kopajtich,et al.  YSK1 is activated by the Golgi matrix protein GM130 and plays a role in cell migration through its substrate 14-3-3ζ , 2004, The Journal of cell biology.

[28]  Michael D Schaller,et al.  NMR Solution Structure of the Focal Adhesion Targeting Domain of Focal Adhesion Kinase in Complex with a Paxillin LD Peptide , 2004, Journal of Biological Chemistry.

[29]  C. Liquori,et al.  Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. , 2003, American journal of human genetics.

[30]  Gilles Labesse,et al.  Molecular recognition of paxillin LD motifs by the focal adhesion targeting domain. , 2003, Structure.

[31]  Chi-Ying F. Huang,et al.  Caspase Activation of Mammalian Sterile 20-like Kinase 3 (Mst3) , 2002, The Journal of Biological Chemistry.

[32]  Troels Z. Kristiansen,et al.  Cloning of MASK, a Novel Member of the Mammalian Germinal Center Kinase III Subfamily, with Apoptosis-inducing Properties* , 2002, The Journal of Biological Chemistry.

[33]  R. Liddington,et al.  The focal adhesion targeting (FAT) region of focal adhesion kinase is a four-helix bundle that binds paxillin , 2002, Nature Structural Biology.

[34]  C. Turner,et al.  Molecular Dissection of Actopaxin-Integrin-linked Kinase-Paxillin Interactions and Their Role in Subcellular Localization* , 2002, The Journal of Biological Chemistry.

[35]  A. Ridley,et al.  Rho family proteins: coordinating cell responses. , 2001, Trends in cell biology.

[36]  Michael D Schaller,et al.  Paxillin: a focal adhesion-associated adaptor protein , 2001, Oncogene.

[37]  A. Ridley Rho GTPases and cell migration. , 2001, Journal of cell science.

[38]  J. Dichgans,et al.  CCM1 gene mutations in families segregating cerebral cavernous malformations , 2001, Neurology.

[39]  C. Turner,et al.  Actopaxin, a New Focal Adhesion Protein That Binds Paxillin Ld Motifs and Actin and Regulates Cell Adhesion , 2000, The Journal of cell biology.

[40]  J. M. Broome,et al.  The Role of Focal Adhesion Kinase Binding in the Regulation of Tyrosine Phosphorylation of Paxillin* , 1999, The Journal of Biological Chemistry.

[41]  C. Turner,et al.  Paxillin LD4 Motif Binds PAK and PIX through a Novel 95-kD Ankyrin Repeat, ARF–GAP Protein: A Role in Cytoskeletal Remodeling , 1999, The Journal of cell biology.

[42]  C. Turner,et al.  Paxillin LD motifs may define a new family of protein recognition domains , 1998, Nature Structural &Molecular Biology.

[43]  M. Brown,et al.  Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding , 1996, The Journal of cell biology.

[44]  C. Sander,et al.  Dali: a network tool for protein structure comparison. , 1995, Trends in biochemical sciences.

[45]  S. Schreiber,et al.  Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. , 1995, Science.

[46]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[47]  C. Turner,et al.  Primary sequence of paxillin contains putative SH2 and SH3 domain binding motifs and multiple LIM domains: identification of a vinculin and pp125Fak-binding region. , 1994, Journal of cell science.

[48]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[49]  C. Turner,et al.  Paxillin: a new vinculin-binding protein present in focal adhesions , 1990, The Journal of cell biology.

[50]  M. Hadley,et al.  Cerebral cavernous malformations. Incidence and familial occurrence. , 1988, The New England journal of medicine.

[51]  M. Clanet,et al.  Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. , 2005, American journal of human genetics.

[52]  A. Hall,et al.  Cell migration: Rho GTPases lead the way. , 2004, Developmental biology.

[53]  Ian W. Davis,et al.  MolProbity: structure validation and all-atom contact analysis for nucleic acids and their complexes , 2004 .

[54]  Roman A. Laskowski,et al.  PDBsum: summaries and analyses of PDB structures , 2001, Nucleic Acids Res..